(R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione

Hunan Huateng Pharmaceutical Co., Ltd (hereinafter referred to as Huateng Pharma), founded in 2013, is a one-stop contract development and manufacturing organization (CDMO) to manufacture and supply researchers with PEG raw materials & PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Today, Huateng Pharma employs more than 400 full time staff, and set up a professional and efficient R&D team with more than 10 national, provincial and municipal experts.

At present, Huateng Pharma has established a 5000 square meters R&D center , equipped with nearly 100 sets of high-end analytical and testing instruments and automatic reaction equipment, such as 400 MHz NMR system, Agilent LC/MS, Waters HPLC, Agilent Intelligent GC system, etc., which can ensure fast and efficient completion of various customized orders from customers. 

And we have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we are an ideal partner for global clinical development. Now, we have established cooperative relationships with more than 500 pharmaceutical companies at home and abroad.